-
GMM Pfaudler acquires De Dietrich Process Systems’ Glass Lined Equipment manufacturing’s Hyderabad facility
expresspharma
July 02, 2020
A consideration of Euro 6.25 million will be paid for the proposed transaction subject to completion of the final due diligence and other documentation.
-
Carlyle Group to acquire 20% stake in India-based Piramal Pharma for $490m
pharmaceutical-business-review
July 01, 2020
US private equity firm Carlyle Group has agreed to acquire a stake of 20% stake in Piramal Pharma, the pharmaceutical business of Indian conglomerate Piramal Enterprises, in a deal worth up to $490m.
-
Carlyle Group to acquire 20 per cent stake in Piramal Pharma
expresspharma
June 28, 2020
The transaction worth $490 million is expected to close in 2020, subject to customary closing conditions and regulatory approvals.
-
Boehringer to sell stake in Hikma
pharmatimes
June 24, 2020
Boehringer Ingelheim Invest has announced plans to pull its investment in Hikma Pharmaceuticals.
-
Apple Tree Partners Portfolio Company Corvidia Therapeutics to be Acquired by Novo Nordisk
americanpharmaceuticalreview
June 23, 2020
Apple Tree Partners (ATP) will exit its ownership stake in Corvidia Therapeutics, a precision cardiovascular therapeutics company, with Novo Nordisk’s acquisition of Corvidia.
-
Piramal Acquires Facility from G&W Laboratories
contractpharma
June 23, 2020
Expands its offerings by adding solid oral dosage form capabilities in North America.
-
Piramal Pharma to acquire manufacturing facility from G&W Laboratories in the US
expresspharma
June 22, 2020
Located in Sellersville, Pennsylvania, this facility will broaden the offering of Piramal Pharma Solutions (PPS) by adding solid oral dosage form capabilities (tablets and capsules) in North America.
-
Melinta to Acquire Tetraphase Pharmaceuticals
americanpharmaceuticalreview
June 19, 2020
Melinta Therapeutics announced that on June 4, 2020, it entered into a definitive merger agreement with Tetraphase Pharmaceuticals.
-
Supernus Completes Acquisition of CNS Portfolio from US WorldMeds
americanpharmaceuticalreview
June 19, 2020
Supernus Pharmaceuticals announced the closing of the acquisition of the CNS portfolio of US WorldMeds, a privately-held biopharmaceutical company.
-
The Creative Engagement Group buys Cormis
pharmatimes
June 17, 2020
The Creative Engagement Group (TCEG), part of the Huntsworth healthcare and communications group, has bought Cormis, a strategic communications and training consultancy for the pharmaceutical industry.